微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 63.53% | 1.05% | 0.45% | 44/140 | 52.83% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 63.24% | -5.15% | 11% | 46/140 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 56.98% | -11.18% | -5.51% | 63/140 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 60.3% | -4.94% | -4.09% | 56/140 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 62.87% | -2.29% | -5.71% | 50/140 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 66.67% | 0.56% | 3.94% | 32/140 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 64.15% | 2.45% | 1.12% | 47/140 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 63.43% | 0.95% | -1.41% | 53/140 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 64.34% | 1.24% | -2.96% | 48/140 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 66.3% | 1.54% | 5.9% | 41/140 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 62.61% | 20.81% | -0.36% | 53/140 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 62.84% | 16.54% | -1.13% | 50/140 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 63.55% | 12.36% | -2.67% | 50/140 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 65.3% | 2.18% | 26% | 43/140 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 51.82% | -11.36% | -3.88% | 77/140 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 53.92% | -17.9% | -4.67% | 72/140 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 56.56% | -17.75% | -11.49% | 69/140 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 63.91% | -9.35% | 9.31% | 45/140 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 58.46% | -15.3% | -10.98% | 70/140 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 65.67% | -8.21% | -4.5% | 44/140 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 68.76% | -2.47% | -2.46% | 44/140 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 70.5% | 4.61% | 2.14% | 32/140 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 69.02% | 5.85% | -3.52% | 46/140 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 71.54% | 9.7% | 1.46% | 28/140 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 70.51% | 8.17% | 4.63% | 36/140 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 67.39% | 9.5% | 3.35% | 27/140 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 65.21% | 6.92% | -0.01% | 52/140 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 65.22% | 7.54% | 0.05% | 27/140 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 65.18% | 7.4% | 5.91% | 34/140 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 61.55% | 0.75% | 0.92% | 23/140 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 60.99% | -0.35% | 0.57% | 53/140 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 60.64% | -3.3% | -0.08% | 23/140 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 60.69% | -5.96% | -0.66% | 26/140 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 61.09% | -5.91% | -0.18% | 21/140 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 61.2% | -10.65% | -2.41% | 48/140 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 62.71% | -9.67% | -2.82% | 20/140 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 64.53% | -7.67% | -0.6% | 23/140 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 64.93% | -6.82% | -5.21% | 17/140 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 68.49% | 2.58% | -1.35% | 29/140 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 69.43% | 6% | -0.67% | 8/140 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 69.89% | 5.64% | 0.32% | 14/140 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 69.67% | 12.76% | 4.35% | 7/140 | 50.24% | 健帆生物 | 83.86% | 行业排名> |